- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Scientist's Selfless Act Could Provide a Lead for Treating TNBC
Dr Koss refused preoperative chemotherapy to avoid damaging her virulent cells, which could later be cultured and could likely provide therapeutic leads.
This year, an estimated 232,000 American women will learn they have breast cancer. On April 28, Kim Koss found out she was one of them.
She took the news as many women do, with shock, fear and sadness. Two weeks later, the news got worse. Hers was a triple-negative cancer, a fast-growing form not fueled by the estrogen, progesterone or HER2/neu gene that are at play in most breast cancers. It meant commonly used drugs and treatments have little benefit for her.
The implications were not lost on Koss, who has a doctorate in biomedical sciences and years of experience with cellular research. Her prognosis was listed as “poor.” “I knew what I was facing,” she says.
It could have immobilized her. Less than a month after her diagnosis, though, her scientist side took charge of what the patient side could not.
Original report: http://cin.ci/1m5Jkn4
Source: Cincinatti
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
